Article Information
History
- April 18, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Erin Williams1,3,
- Jordan Colson4,
- Ranjini Valiathan4,
- Juan Manuel Carreño6,8,
- Florian Krammer6,7,8,
- Michael Hoffer1,5,
- Suresh Pallikkuth2,
- Savita Pahwa2,* and
- David Andrews4,*
- 1Department of Otolaryngology, University of Miami Miller School of Medicine, Miami, Florida, 33136 USA
- 2Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida, 33146, USA
- 3Department of Biomedical Engineering, University of Miami, Miami, Florida, 33136, USA
- 4Department of Pathology and Laboratory Medicine, University of Miami Miller School of Medicine, Miami, Florida, 33136, USA
- 5Department of Neurological Surgery, University of Miami, Miller School of Medicine, Miami, Florida, 33136, USA
- 6Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA
- 7Department of Pathology, Molecular and Cell-based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, 10029, USA
- 8Center for Vaccine Research and Pandemic Preparedness (C-VARPP), Icahn School of Medicine at Mount Sinai, New York, NY, USA
- ↵*Corresponding authors:
David Andrews, M.D. at the Department of Pathology, University of Miami Miller School of Medicine, Department of Pathology and Laboratory Medicine, JMH - Holtz 2026, 1611 NW 12 Avenue, Miami, FL 33136, USA, Phone: 305-585-5886 Fax: 304-243-2013, Email: dandrews{at}miami.edu, Savita Pahwa, M.D. at the Department of Microbiology and Immunology (Pediatrics and Medicine), University of Miami Miller School of Medicine, 1580 NW 10th Avenue; BCRI 712, Miami, FL 33136, USA Phone: 305-243-7732, Fax: 305-243-7211, Email: spahwa{at}med.miami.edu
Posted April 18, 2022.
PERMISSIVE OMICRON BREAKTHROUGH INFECTIONS IN INDIVIDUALS WITH BINDING OR NEUTRALIZING ANTIBODIES TO ANCESTRAL SARS-CoV-2
